Clinical Trial

Personalized Therapy Study - Attain Stability Quad Post-Approval Study

Study acronym: ASQ
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this Post-Approval Study (PAS) is to evaluate the long-term performance of the Model 4798 Left Ventricular (LV) lead in a real-world patient population. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the Model 4798 LV lead and is integrated within the Product Surveillance Registry (PSR).
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-07-17; most recent amendment 2026-02-02.
Status change: Recruiting → Active, Not Recruiting 2023-12-04
Trial Details
NCT Number NCT04024943
Lead Sponsor Medtronic
Conditions Heart Failure
Enrollment 1,092 participants
Start Date 2017-08-21
Primary Completion 2027-07 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-04